超声引导下竖脊肌平面阻滞对微创冠状动脉旁路移植术后镇痛及恢复质量的有效性:随机对照试验方案
本研究为双盲前瞻性随机安慰剂对照试验方案,拟纳入60例择期全麻下微创冠状动脉旁路移植术(MIDCAB)成人患者,随机接受术前单次超声引导下竖脊肌平面阻滞(ESPB,0.5%罗哌卡因30 mL)或0.9%生理盐水。主要结局为术后6、12、18、24、48小时静息状态数字评定量表(NRS)评分组间差异,旨在验证ESPB降低MIDCAB术后疼痛评分的假设。
要点
- 方案纳入60例MIDCAB手术成人患者,随机分为ESPB组(0.5%罗哌卡因30 mL)与对照组(0.9%生理盐水)。
- 主要结局为术后6、12、18、24、48小时静息NRS评分组间差异。
- 次要结局包括深吸气NRS评分、氢吗啡酮用量及24小时和48小时恢复质量(QoR-15)。
核心结论
- 本研究为一种新型随机对照研究,评估术前超声引导下单次单侧ESPB对MIDCAB手术镇痛及患者恢复质量的作用。
- 研究结果将描述MIDCAB术后急性疼痛程度及临床结局,可能有助于优化该特定人群的镇痛方案选择并改善患者舒适度。
研究设计与样本
- 双盲前瞻性随机安慰剂对照试验方案,经北京大学人民医院伦理审查委员会审查批准,已在中国临床试验注册中心前瞻性注册(注册号ChiCTR2100052810),注册日期2021年11月5日。
- 计划纳入60例拟在全麻下接受MIDCAB手术的成年患者,男女不限,随机分配至ESPB组或对照组。
关键数值与推荐
- ESPB组术前接受单次超声引导下竖脊肌平面阻滞,注射0.5%罗哌卡因30 mL;对照组注射0.9%生理盐水。
- 主要结局为两组术后6、12、18、24、48小时静息状态NRS评分的差异。
- 次要结局包括术后48小时内深吸气时NRS评分、术后氢吗啡酮消耗量,以及使用QoR-15量表评估的24小时和48小时患者恢复质量。
- 其他结局包括术中芬太尼需求量、术后需追加补救镇痛药、术后气管拔管及胸管拔除时间、术后恶心呕吐(PONV)及术后认知功能障碍(POCD)发生率、重症监护室(ICU)停留时间(LOS)、出院时间及30天死亡率,并评估不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimally invasive direct coronary artery bypass (MIDCAB) surgery offers an effective option for coronary artery disease (CAD) patients with the avoidance of median sternotomy and fast postoperative recovery. However, MIDCAB is still associated with significant postoperative pain which may lead to delayed recovery. The erector spinae plane block (ESPB) is a superficial fascial plane block. There have not been randomized controlled trials evaluating the effects of ESPB on analgesia and patient recovery following MIDCAB surgery. We therefore designed a double-blind prospective randomized placebo-controlled trial, aiming to prove the hypothesis that ESPB reduces postoperative pain scores in patients undergoing MIDCAB surgery. METHODS: The study protocol has been reviewed and approved by the Ethical Review Committee of Peking University People's Hospital. Sixty adult patients of either sex scheduled for MIDCAB surgery under general anesthesia (GA) will be included. Patients will be randomly allocated to receive either a preoperative single-shot ESPB with 30 mL of ropivacaine 0.5% (ESPB group) or normal saline 0.9% (control group). The primary outcomes are the difference between the two groups in numeric rating scale (NRS) scores at rest at different time points (6, 12, 18, 24, 48 h) after surgery. The secondary outcomes include NRS scores on deep inspiration within 48 h, postoperative hydromorphone consumption, and quality of patient recovery at 24 h and 48 h, using the Quality of Recovery-15 (QoR-15) scale. The other outcomes include intraoperative fentanyl requirements, the need for additional postoperative rescue analgesics, time to tracheal extubation and chest tube removal after surgery, incidence of postoperative nausea and vomiting (PONV) and postoperative cognitive dysfunction (POCD), intensive care unit (ICU) length of stay (LOS), hospital discharge time, and 30-day mortality. Adverse events will be also evaluated. DISCUSSION: This is a novel randomized controlled study evaluating a preoperative ultrasound-guided single-shot unilateral ESPB on analgesia and quality of patient recovery in MIDCAB surgery. The results of this study will characterize the degree of acute postoperative pain and clinical outcomes following MIDCAB. Our study may help optimizing analgesia regimen selection and improving patient comfort in this specific population. TRIAL REGISTRATION: The study was prospectively registered with the Chinese Clinical Trial Registry (trial identifier: ChiCTR2100052810). Date of registration: November 5, 2021.
引用
- Xin L, Wang L, Feng Y, et al. Efficacy of ultrasound-guided erector spinae plane block on analgesia and quality of recovery after minimally invasive direct coronary artery bypass surgery: protocol for a randomized controlled trial. Trials. 2024. PMID: 38243276. doi:10.1186/s13063-024-07925-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。